X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
index medicus (22) 22
female (20) 20
male (17) 17
adult (16) 16
endocrinology & metabolism (16) 16
diabetes (13) 13
insulin (12) 12
middle aged (12) 12
glucose (11) 11
insulin resistance (10) 10
metabolic syndrome (10) 10
metabolism (10) 10
body mass index (9) 9
obesity (9) 9
animals (7) 7
cohort studies (7) 7
cross-sectional studies (7) 7
aged (6) 6
hypertension (6) 6
young adult (6) 6
endocrinology (5) 5
pasireotide (5) 5
tumors (5) 5
diabetes mellitus (4) 4
diagnosis (4) 4
exercise (4) 4
fibroblast growth factor 21 (4) 4
fibroblast growth factors - metabolism (4) 4
follow-up studies (4) 4
in-vitro (4) 4
ketoconazole (4) 4
lipids (4) 4
mice (4) 4
mortality (4) 4
plasma (4) 4
ppar-alpha (4) 4
retrospective studies (4) 4
review (4) 4
sensitivity (4) 4
somatostatin - analogs & derivatives (4) 4
somatostatin - therapeutic use (4) 4
surgery (4) 4
acromegaly (3) 3
association (3) 3
cardiovascular disease (3) 3
diabetes mellitus, type 2 - blood (3) 3
diabetes mellitus, type 2 - complications (3) 3
diabetes mellitus, type 2 - drug therapy (3) 3
diabetes mellitus, type 2 - epidemiology (3) 3
disease (3) 3
diseases of the endocrine glands. clinical endocrinology (3) 3
endocrinology, diabetes and metabolism (3) 3
energy balance (3) 3
fgf21 (3) 3
follow-up (3) 3
glucose metabolism (3) 3
growth factors (3) 3
health aspects (3) 3
insulin - blood (3) 3
insulin sensitivity (3) 3
insulin-resistance (3) 3
laboratories (3) 3
ligands (3) 3
medicine, general & internal (3) 3
metabolic syndrome - metabolism (3) 3
mexico - epidemiology (3) 3
mifepristone (3) 3
morbidity (3) 3
neuroendocrinology and pituitary (3) 3
obese (3) 3
original research (3) 3
patients (3) 3
physiological aspects (3) 3
pituitary (3) 3
pituitary acth hypersecretion - drug therapy (3) 3
population (3) 3
prevalence (3) 3
research article (3) 3
risk factors (3) 3
secretion (3) 3
somatostatin analogs (3) 3
studies (3) 3
targets and therapy [diabetes, metabolic syndrome and obesity] (3) 3
triglycerides (3) 3
type 2 diabetes (3) 3
type 2 diabetes mellitus (3) 3
abdomen (2) 2
abdominal obesity (2) 2
abridged index medicus (2) 2
acth-secreting pituitary adenoma - genetics (2) 2
adenoma - drug therapy (2) 2
adenoma - genetics (2) 2
adiponectin (2) 2
adolescents (2) 2
adrenocorticotropic hormone (2) 2
alanine aminotransferase (2) 2
anthropometry (2) 2
antineoplastic agents - therapeutic use (2) 2
article subject (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Design, Development and Therapy, ISSN 1177-8881, 01/2016, Volume 10, pp. 227 - 239
Morbidity and mortality rates in patients with active acromegaly are higher than the general population. Adequate biochemical control restores mortality to... 
Somatostatin analogs | Growth hormone | Pasireotide | Insulin-like growth factor 1 | Somatostatin receptor ligand | Emerging treatments | MORTALITY | SOM230 | CHEMISTRY, MEDICINAL | somatostatin analogs | pasireotide | ORAL OCTREOTIDE | emerging treatments | somatostatin receptor ligand | PITUITARY-ADENOMAS | SOMATOSTATIN RECEPTOR INTERNALIZATION | GROWTH-HORMONE | MEDICAL THERAPY | MULTIMODAL THERAPY | PHARMACOLOGY & PHARMACY | growth hormone | SECRETION | insulin-like growth factor 1 | PHASE-I | Acromegaly - drug therapy | Somatostatin - analogs & derivatives | Animals | Somatostatin - adverse effects | Humans | Drug Design | Somatostatin - administration & dosage | Acromegaly - physiopathology | Octreotide | Somatostatin - therapeutic use | Delayed-Action Preparations | Drug Delivery Systems | Acromegaly | Somatotropin | Care and treatment | Health aspects | Mortality | Diabetes therapy | Therapy | Cardiac arrhythmia | Nuclear magnetic resonance--NMR | Peptides | Medical services | Amino acids | Sleep apnea | Insulin-like growth factors | Kinases | Cancer therapies | Proteins | Hyperglycemia | Surgery | Somatostatin | Growth factors | Hypertension | Diabetes mellitus | Shrinkage | FDA approval | Metabolism | Insulin | Disease control | Patients | Morbidity | Ligands | Insulin resistance | Growth hormones | Diabetes | Endocrinology | Tumors
Journal Article
FRONTIERS IN PHYSIOLOGY, ISSN 1664-042X, 02/2019, Volume 10, p. 37
Interest has been focused on differentiating anatomical, molecular, and physiological characteristics of the types of mammalian adipose tissues. White adipose... 
fibroblast growth factor 21 | ANTIDIABETIC ACTIONS | PPAR-ALPHA | glucose | PHYSIOLOGY | NATRIURETIC PEPTIDES | exercise | energy balance | free fatty acids | SKELETAL-MUSCLE | BODY-WEIGHT | GLUCOSE-HOMEOSTASIS | ENERGY-EXPENDITURE | FAT THERMOGENESIS | UNCOUPLING PROTEIN-1 | noradrenaline | irisin | insulin resistance | UCP1 EXPRESSION
Journal Article
The Journal of Urology, ISSN 0022-5347, 04/2018, Volume 199, Issue 4, pp. e804 - e805
Journal Article
Minerva endocrinologica, 09/2016, Volume 41, Issue 3, p. 324
Cushing's Syndrome (CS) is a serious endocrine disease that results from the adverse clinical consequences of chronic exposure to high levels of... 
Pituitary ACTH Hypersecretion - radiotherapy | Humans | Pituitary ACTH Hypersecretion - surgery | Hormone Antagonists - therapeutic use | Drug Therapy, Combination | Hydrocortisone - blood | Pituitary ACTH Hypersecretion - drug therapy
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 11/2016, Volume 23, Issue 11, pp. 857 - 870
Cushing’s syndrome is caused by excessive adrenocorticotropic hormone (ACTH) secretion derived from pituitary corticotroph tumors (Cushing disease) or from... 
E2F1 | Ser-337 E2F1 | ectopic Cushing’s syndrome | proopiomelanocortin (POMC)
Journal Article
Minerva Endocrinologica, ISSN 0391-1977, 09/2016, Volume 41, Issue 3, pp. 324 - 340
Journal Article
Redox Biology, ISSN 2213-2317, 04/2017, Volume 11, Issue C, pp. 335 - 341
Journal Article
Journal Article
Journal Article